Last week, a Boston Consulting Group (BCG) report calculated that the failed mega-deals of 2014, such as pharma giant Pfizer 's bid to acquire AstraZeneca and 21st Century Fox's courtship of rival Time Warner, cut the total monetary value of announced M&A by nearly 25 percent for the year.